NH
Nash Huw M. Chief Operating Officer
Other M
US US · SEC (Form 4)
Discover the full record of transactions filed by Nash Huw M., Chief Operating Officer. Insider active across 1 companies, notably Stoke Therapeutics, Inc.. Cumulatively, 16 filings have been logged. The latest transaction was disclosed on 3 January 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 16 total
€7,317 3,800 shares @ €1.9255 0.0004% mcap 10.6% of flow
Common Stock
SEC:0001209191-22-001849 · 3 Jan 2022
€7,317 3,800 shares @ €1.9255 0.0004% mcap 5.3% of flow
Common Stock
SEC:0001209191-22-001849:0 · 3 Jan 2022
€11,017 5,700 shares @ €1.9329 0.0006% mcap 16.0% of flow
Common Stock
SEC:0001209191-21-067950 · 1 Dec 2021
€11,017 5,700 shares @ €1.9329 0.0006% mcap 8.0% of flow
Common Stock
SEC:0001209191-21-067950:0 · 1 Dec 2021
€7,201 3,800 shares @ €1.895 0.0004% mcap 10.4% of flow
Common Stock
SEC:0001209191-21-062772 · 1 Nov 2021
€7,201 3,800 shares @ €1.895 0.0004% mcap 5.2% of flow
Common Stock
SEC:0001209191-21-062772:0 · 1 Nov 2021
€10,785 5,700 shares @ €1.8921 0.0006% mcap 15.6% of flow
Common Stock
SEC:0001209191-21-059111 · 1 Oct 2021
€10,785 5,700 shares @ €1.8921 0.0006% mcap 7.8% of flow
Common Stock
SEC:0001209191-21-059111:0 · 1 Oct 2021
€10,542 5,700 shares @ €1.8495 0.0006% mcap 15.3% of flow
Common Stock
SEC:0001209191-21-054552 · 1 Sept 2021
€10,542 5,700 shares @ €1.8495 0.0006% mcap 7.6% of flow
Common Stock
SEC:0001209191-21-054552:0 · 1 Sept 2021
€10,512 5,700 shares @ €1.8443 0.0006% mcap 15.2% of flow
Common Stock
SEC:0001209191-21-049793 · 2 Aug 2021
€10,512 5,700 shares @ €1.8443 0.0006% mcap 7.6% of flow
Common Stock
SEC:0001209191-21-049793:0 · 2 Aug 2021
€10,538 5,700 shares @ €1.8487 15.3% of flow
Common Stock
SEC:0001209191-21-045097 · 1 Jul 2021
€10,538 5,700 shares @ €1.8487 0.0006% mcap 7.6% of flow
Common Stock
SEC:0001209191-21-045097:0 · 1 Jul 2021
€1,031 575 shares @ €1.7925 1.5% of flow
Common Stock
SEC:0001209191-21-037839 · 1 Jun 2021
€1,031 575 shares @ €1.7925 0.0001% mcap 0.7% of flow
Common Stock
SEC:0001209191-21-037839:0 · 1 Jun 2021
About Nash Huw M. Nash Huw M. is an executive at Stoke Therapeutics, Inc.